US Map / Nevada
State NV

Clinical Trials in Nevada

Recruiting clinical trials with at least one study location in Nevada. Data updated daily from ClinicalTrials.gov.

Total Trials
84
Recruiting Now
84
← Back to US Map
Top Conditions in Nevada
Malignant Solid Neoplasm (3)Melanoma (2)Non-Hodgkin Lymphoma (2)Endometrial Cancer (2)Chronic Lymphocytic Leukemia (2)Agitation (2)Alzheimer Disease (2)Major Depressive Disorder (2)Acute Myeloid Leukemia (2)Asthma (2)Narcolepsy Type 1 (2)Narcolepsy Type 2 (2)
NCT06388590 N/A
Recruiting
Acupuncture for Chronic Pelvic Pain
Condition
Pelvic Pain
Enrollment
64 pts
Location
United States
Sponsor
David Moss
View Trial →
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
View Trial →
NCT06907147 N/A
Recruiting
SPYRAL GEMINI Pilot Study
Condition
Hypertension
Enrollment
175 pts
Location
United States, Australia, Greece
Sponsor
Medtronic Vascular
View Trial →
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
View Trial →
NCT07216482 Phase 3
Recruiting
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-03...
Condition
Hyperlipidemia
Enrollment
975 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT01719055 N/A
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-T...
Condition
Pain
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
Boston Scientific Corporation
View Trial →
Page 4 of 4 — 84 trials total
← Prev